Gynecologic Cancer Curriculum

Inside Knowledge About Gynecologic Cancer logo

Welcome to the Gynecologic Cancer Curriculum intended for primary health care providers! CDC’s Division of Cancer Prevention and Control developed this curriculum to inform health care providers about gynecologic cancers. This project is part of CDC’s Inside Knowledge: Get the Facts about Gynecologic Cancer (Inside Knowledge) campaign, which raises awareness of the five main types of gynecologic cancer: cervical, ovarian, uterine, vaginal, and vulvar.

This material was developed specifically for and tested with internal medicine resident physicians, but the target audience for this material is any primary health care provider who treats adult female patients. This material could apply to primary care physicians (those practicing and in training) in internal medicine, family medicine, or obstetrics and gynecology, as well as nurses and physician assistants. However, because the modules were tested with internal medicine residents, other providers should consider their specific needs and approaches

Continuing education is available for completion of this activity.


The goals of the Gynecologic Cancer Curriculum are to—

  • Increase primary health care provider’s knowledge of cervical, ovarian, uterine, vaginal, and vulvar cancers including—
    • Risk factors.
    • Symptoms.
    • Prevention strategies.
    • Clinical management basics.
    • Follow-up to improve patient care decisions.
  • Align the care that health care professionals provide to their patients with evidence-based recommendations on cervical, ovarian, uterine, vaginal, and vulvar cancer prevention and screening.
  • Increase knowledge of genetic causes of gynecologic cancers.
  • Increase knowledge of human papillomavirus (HPV) and the HPV vaccine.


Upon completion of these modules, learners will be able to—

  • List gynecologic cancer risk factors, signs, and symptoms.
  • List evidence-based cervical cancer screening recommendations.
  • Describe why an extended interval for cervical cancer screening is most appropriate for average-risk women.
  • Describe appropriate follow-up care for abnormal cervical cancer screening test results.
  • List evidence-based human papillomavirus (HPV) vaccination recommendations.
  • Identify the need to send patients with suspected or diagnosed gynecologic cancers to a gynecologist or gynecologic oncologist.
  • Identify patients at high risk for developing gynecologic cancer.
  • List evidence-based recommendations for genetic counseling and testing for those at high risk of developing gynecologic cancer.
  • Describe the risks of screening average-risk asymptomatic patients for ovarian cancer.

Learn more about this curriculum.

Accreditation Statements

CME: The Centers for Disease Control and Prevention is accredited by the Accreditation Council for Continuing Medical Education (ACCME®) to provide continuing medical education for physicians. The Centers for Disease Control and Prevention designates this enduring activity for a maximum of 1.5 AMA PRA Category 1 Credits.™ Physicians should claim only the credit commensurate with the extent of their participation in the activity.

CNE: The Centers for Disease Control and Prevention is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation. This activity provides 1.3 contact hours.

CPH: The Centers for Disease Control and Prevention is a pre-approved provider of Certified in Public Health (CPH) recertification credits and is authorized to offer 2.0 CPH recertification credits for this program.

CDC is an approved provider of CPH Recertification Credits by the National Board of Public Health Examiners. Effective October 1, 2013, the National Board of Public Health Examiners (NBPHE) accepts continuing education units (CEU) for CPH recertification credits from CDC. Please select CEU as your choice for continuing education when registering for a course on TCEOnline. Learners seeking CPH should use the guidelines provided by the NBPHE for calculating recertification credits. For assistance please contact NBPHE.external icon

Continuing Education

Origination Date: October 26, 2015
Renewal Date: October 26, 2017
Expiration Date: October 26, 2019
Hardware/Software: Computer-Internet
Materials: None
Target Audience: Any primary health care provider who treats adult female patients
Prerequisites: None
Format: Web-based
Contact Information: Division of Cancer Prevention and Control (800) CDC-INFO (800-232-4636)
Fees: No fees are charged for CDC’s CE activities.

How to Receive Continuing Education

Continuing education (CE) for this course is available only through CDC’s Training and Continuing Education Online (TCEO) system. Please follow the instructions below. You must complete the online evaluation by October 25, 2017 to receive continuing education or a certificate of completion. If you have difficulty accessing the course, call (800) 41-TRAIN (87246) or send a message using this form.

After you have completed the Gynecologic Cancer Curriculum, complete the following steps to access the post-test—

  1. Visit
  2. Login or register as a new user.
  3. On the Online Search page, type WB2549 in the Keyword Search field and click View.
  4. Click on the course name, select the type of CE you would like to receive, and click Submit.
  5. Review or complete the demographic information and click Submit.
  6. Click on “Click Here if you have completed the course and would like to take evaluation and/or posttest.”
  7. Enter the verification code GYNCA and click Submit.
  8. Complete the evaluation and click Submit.
  9. The post-test will begin.

Pass the post-test with a score of 80% or better. You may retake the post-test once. A record of your course completion and your CE certificate will be posted in the Transcript and Certificate section on the Participant Services page.


In compliance with continuing education requirements, all presenters must disclose any financial or other associations with the manufacturers of commercial products, suppliers of commercial services, or commercial supporters, as well as any use of unlabeled product(s) or product(s) under investigational use. CDC, our planners, content experts, and their spouses/partners wish to disclose they have no financial interests or other relationships with the manufacturers of commercial products, suppliers of commercial services, or commercial supporters. Content experts reviewed content to ensure there is no bias. Content will not include any discussion of the unlabeled use of a product or a product under investigational use. CDC does not accept commercial support.

Page last reviewed: September 8, 2017